How Moderna’s AI Infrastructure Is Revolutionizing Vaccine Development, Drug Discovery And More

Most are familiar with the name Moderna and its landmark role in developing one of the first COVID-19 vaccines, but few know how the company leveraged AI to accelerate its creation. Today, Moderna’s Director of AI and Data Science, Dr. Andrew Giessel, joins us on The ConversAItion to discuss how his team leverages AI to accelerate the mRNA research process for a number of different applications, the importance of training employees in AI basics and how computer science and biology can work hand-in-hand in the future to transform the pharmaceutical industry. You can find Andrew on Twitter @giessel. 

Om Podcasten

Host Jim Freeze, a high-energy tech enthusiast and CMO at conversational AI company Interactions, is on a quest to understand the impact of AI on business and society. AI materializes in business, academic and government innovations. It finishes our texts, analyzes complex medical data and if you ask, can recite the weather forecast or play your favorite song. Through dialogue and debate with AI executives and academics, Jim’s peeling back the layers on the ways the technology is changing our lives to understand how its impact can be as productive as possible. For more, visit interactions.com/podcast.